Can Brainstorm Cell Therapeutics, Inc Bounce Back? 52-Week Performance and Analyst Predictions

ZM Stock

Brainstorm Cell Therapeutics, Inc (BCLI) current stock price is $1.17. During the last trading session, the stock soared, reaching $24.35 after opening at $1.17. The stock’s lowest point was $6.0 before it closed at $1.2.

Brainstorm Cell Therapeutics, Inc’s stock market performance has been somewhat irregular.

52-week price history of BCLI Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Brainstorm Cell Therapeutics, Inc’s current trading price is -81.43% away from its 52-week high, while its distance from the 52-week low is 61.76%. The stock’s price range for this period has remained between $0.72 and $6.30. The Healthcare sector company’s shares managed to surpass a trading volume of around 1.98 million for the day, which was noticeably higher compared to the shares’ average daily volume of 1.35 million over the last three months.

Financial Performance and Market Capitalization

Brainstorm Cell Therapeutics, Inc (BCLI) has experienced a quarterly rise of 50.39% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 11.51M and boasts a workforce of 27 employees.

Analysts’ Ratings For Brainstorm Cell Therapeutics, Inc

As of right now, 0 analyst is rating Brainstorm Cell Therapeutics, Inc as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2310, with a change in price of -0.5600. Similarly, Brainstorm Cell Therapeutics, Inc recorded 929,256 in trading volume during the last 100 days, posting a change of -32.37%.

BCLI Stock Stochastic Average

As of today, the raw stochastic average of Brainstorm Cell Therapeutics, Inc over the last 50 days is at 18.48%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 50.00%. Further, the company’s Stochastic %K and %D values for the last 20 days were 56.67% and 58.89%, respectively.

BCLI Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded a decrease of -81.29%. However, over the last six months, the performance has been stronger by -42.65%. The price of BCLI decreased -5.65% over the last 30 days. And in the last five days, it has fallen by -4.10%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.